Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MDWD MediWound Ltd
- Stocks
- Healthcare
- NASDAQ: MDWD
Price (delayed)
$21.7
Market cap
$234.32M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.04
Enterprise value
$202.48M
mediwound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutics based on its patented proteolytic enzyme technology to address unmet needs in the fields of severe
Highlights
The equity rose by 35% year-on-year
The company's quick ratio rose by 9% YoY and by 7% QoQ
The net income has plunged by 66% YoY but it has grown by 30% from the previous quarter
The EPS has declined by 48% year-on-year but it has increased by 33% since the previous quarter
MediWound's revenue has decreased by 5% from the previous quarter and by 3.2% YoY
Key stats
What are the main financial stats of MDWD
Market
Valuations
Earnings
Shares outstanding
10.8M
Market cap
$234.32M
Enterprise value
$202.48M
Price to earnings (P/E)
N/A
Price to book (P/B)
7.49
Price to sales (P/S)
12.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.54
Revenue
$19.21M
Gross profit
$2.77M
Operating income
-$20.89M
Net income
-$21.22M
EBIT
-$20.31M
EBITDA
-$18.84M
Free cash flow
-$19.1M
Per share
Balance sheet
Liquidity
EPS
-$2.04
EPS diluted
-$2.04
Free cash flow per share
-$1.77
Book value per share
$2.9
Revenue per share
$1.78
TBVPS
$6.38
Total assets
$69.02M
Total liabilities
$37.74M
Debt
$6.42M
Equity
$31.27M
Working capital
$25.18M
Debt to equity
0.21
Current ratio
2.15
Quick ratio
1.99
Net debt/EBITDA
1.69
Margins
Efficiency
Dividend
EBITDA margin
-98%
Gross margin
14.4%
Net margin
-110.5%
Operating margin
-108.7%
Return on assets
-30.9%
Return on equity
-74.1%
Return on invested capital
-112%
Return on capital employed
-43.1%
Return on sales
-105.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MDWD stock price
How has the MediWound stock price performed over time
Intraday
0.51%
1 week
2.94%
1 month
25.8%
1 year
27.8%
YTD
21.91%
QTD
39.82%
Financial performance
How have MediWound's revenue and profit performed over time
Revenue
$19.21M
Gross profit
$2.77M
Operating income
-$20.89M
Net income
-$21.22M
Gross margin
14.4%
Net margin
-110.5%
MediWound's net margin has shrunk by 72% YoY but it has increased by 26% QoQ
The net income has plunged by 66% YoY but it has grown by 30% from the previous quarter
The company's operating margin fell by 45% YoY and by 13% QoQ
MDWD's operating income is down by 40% YoY and by 8% QoQ
Price vs fundamentals
How does MDWD's price correlate with its fundamentals
Growth
What is MediWound's growth rate over time
Valuation
What is MediWound stock price valuation
P/E
N/A
P/B
7.49
P/S
12.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.54
The EPS has declined by 48% year-on-year but it has increased by 33% since the previous quarter
MDWD's P/B is 41% below its 5-year quarterly average of 12.8 but 23% above its last 4 quarters average of 6.1
The equity rose by 35% year-on-year
The P/S is 149% higher than the 5-year quarterly average of 4.9 and 42% higher than the last 4 quarters average of 8.6
MediWound's revenue has decreased by 5% from the previous quarter and by 3.2% YoY
Efficiency
How efficient is MediWound business performance
MDWD's ROIC has dropped by 196% year-on-year
The return on sales has dropped by 138% year-on-year and by 10% since the previous quarter
MDWD's ROE has shrunk by 79% YoY but it is up by 35% QoQ
The ROA has plunged by 58% YoY but it has grown by 31% from the previous quarter
Dividends
What is MDWD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MDWD.
Financial health
How did MediWound financials performed over time
The company's total assets is 83% higher than its total liabilities
The company's total liabilities fell by 11% QoQ and by 3.7% YoY
The company's total assets rose by 11% YoY but it fell by 6% QoQ
MediWound's debt is 79% lower than its equity
The equity rose by 35% year-on-year
MediWound's debt to equity has decreased by 25% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.